The efficacy of probiotics in experimental autoimmune encephalomyelitis (an animal model for MS): a systematic review

S Valizadeh1, A Majdi Seghinsara2, K Maleki Chollou3

  • 1Department of Food Science and Technology, Faculty of Agriculture and Natural Resources, University of Mohaghegh Ardabili, Ardabil, Iran.

Insights

Probiotics show promise in managing experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis (MS). This review found probiotics significantly impact EAE incidence, weight, and symptoms, suggesting potential therapeutic benefits.

Area of Science:

  • Immunology
  • Microbiology
  • Neuroscience

Background:

  • Probiotics possess immunomodulatory properties with potential benefits for autoimmune diseases like multiple sclerosis (MS).
  • Experimental autoimmune encephalomyelitis (EAE) serves as a key animal model for studying MS pathogenesis and therapeutic interventions.

Purpose of the Study:

  • To systematically review and meta-analyze the effects of probiotics on experimental autoimmune encephalomyelitis (EAE).
  • To evaluate the efficacy of probiotics in preventing and managing EAE as an animal model of MS.

Main Methods:

  • Systematic literature search of Scopus, Web of Science, and PubMed databases up to December 2019.
  • Inclusion of 15 animal studies investigating probiotic effects on EAE.
  • Meta-analysis using random effect models to calculate pooled odd ratios (95% CI) for various EAE outcomes.

Main Results:

  • Probiotics significantly influenced EAE incidence, animal weight gain, and clinical symptom severity.
  • Probiotic strain influenced the effects on EAE duration.
  • Mortality risk was significantly reduced by probiotics, specifically in female animals.

Conclusions:

  • Probiotics demonstrate promising effects in the prevention and management of EAE.
  • Further research may elucidate strain-specific mechanisms and optimize probiotic-based therapeutic strategies for MS.